LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Gross Profit
LeMaitre Vascular Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Gross Profit
$132.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is LeMaitre Vascular Inc's Gross Profit?
Gross Profit
132.8m
USD
Based on the financial report for Mar 31, 2024, LeMaitre Vascular Inc's Gross Profit amounts to 132.8m USD.
What is LeMaitre Vascular Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
11%
Over the last year, the Gross Profit growth was 21%. The average annual Gross Profit growth rates for LeMaitre Vascular Inc have been 15% over the past three years , 12% over the past five years , and 11% over the past ten years .